Share This Page
Drug Price Trends for NDC 46122-0740
✉ Email this page to a colleague
Average Pharmacy Cost for 46122-0740
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GNP MAGNESIUM CITRATE SOLUTION | 46122-0740-38 | 0.00610 | ML | 2025-12-17 |
| GNP MAGNESIUM CITRATE SOLUTION | 46122-0740-38 | 0.00612 | ML | 2025-11-19 |
| GNP MAGNESIUM CITRATE SOLUTION | 46122-0740-38 | 0.00618 | ML | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 46122-0740
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 46122-0740
Introduction
NDC 46122-0740 refers to a specific pharmaceutical product regulated within the U.S. healthcare system, identified via the National Drug Code (NDC) system. While detailed product specifics—including formulation, manufacturer, and therapeutic class—are essential, comprehensive market analysis often begins by contextualizing the drug within its therapeutic category, assessing current demand, competitive landscape, regulatory environment, and pricing trends. This report synthesizes available data to provide an informed projection of market dynamics and pricing trajectories for NDC 46122-0740.
Product Overview and Therapeutic Context
The NDC 46122-0740 corresponds to [Insert Specific Drug Name and Formulation], which is indicated for [e.g., treatment of specific conditions such as diabetes, oncology, neurology, etc.]. The manufacturer’s details are [if available, e.g., ABC Pharmaceuticals]. Its clinical profile, including efficacy, safety, and dosing regimen, influences market size and competitive positioning.
Understanding the drug’s position within its therapeutic category, including whether it’s a branded, generic, or biosimilar, is crucial. For example, if NDC 46122-0740 is a branded innovator’s product, its market share and pricing are likely higher, with potential for patent exclusivity to sustain margins. Conversely, if it’s a generic or biosimilar, competitive pricing pressures and market penetration strategies are more significant.
Current Market Landscape
-
Market Size and Demand Dynamics:
The demand for drugs similar to NDC 46122-0740 is predominantly driven by prevalence of the condition it treats. For example, if it targets a common chronic disease like diabetes, the market size could reach hundreds of millions domestically, intensifying competitiveness and pricing considerations. -
Competitive Environment:
The landscape includes direct competitors—both branded and generic products—as well as biosimilars or alternative therapies that influence pricing and market share. The presence of multiple entrants often exerts downward pressure on prices, especially as patents expire or if biosimilars are authorized. -
Regulatory Status:
Regulatory approvals, patent status, and exclusivity periods (e.g., Orphan Drug designation, Patent Extensions) directly affect market stability and pricing. Recent patent litigations or approvals of biosimilars can alter the competitive landscape. -
Insurance and Reimbursement Factors:
Coverage policies determine patient access and reimbursement levels. Favorable Medicaid and Medicare policies or inclusion in formularies can augment sales volume at stable prices, whereas restrictive policies compress margins.
Pricing Trends and Projections
-
Historical Price Data:
Current prices for products in the same class have shown varying trends. Branded medications typically command higher list prices, with adjustments for inflation, patent status, and market entry of generics/biosimilars. -
Recent Price Movements:
FDA approvals, patent litigations, biosimilar entries, and shifts in payer policies have driven recent pricing fluctuations. For example, the introduction of biosimilars often reduces brand-name drug prices by 15-30% within two years of entry. -
Future Price Projections:
Assuming patent exclusivity remains intact, the drug’s price may stabilize or slightly increase, especially if new indications are approved or if supply chain constraints emerge. Conversely, imminent biosimilar entry or loss of patent protections could precipitate significant reductions—potentially 20-50%, aligned with historical biosimilar price erosion trends [1]. -
Market Penetration and Volume Effect:
The expansion of approved indications and increased payor acceptance can lead to higher volume sales, partially offsetting price declines. Additionally, market expansion into emerging economies or through value-based pricing agreements can influence overall revenue.
Factors Influencing Pricing and Market Trajectory
-
Regulatory Developments:
FDA approvals for new indications or biosimilar entrants directly influence pricing and market share. -
Patent and Exclusivity Timelines:
The expiration date of exclusivity periods informs the timeline for potential price erosion. -
Competitive Entry:
Speed and scale of biosimilar or generic competition determine the pace of price reductions. -
Reimbursement Policies:
Changes in insurance coverage and government reimbursement programs modulate consumer access and price ceilings. -
Manufacturing and Supply Chain Stability:
Supply disruptions can temporarily inflate prices; conversely, overcapacity can prompt price cuts.
Summary of Market Outlook
Considering patent exclusivity, current demand, and competitive pressures, the price trajectory for NDC 46122-0740 is expected to follow a typical lifecycle pattern:
-
Short-Term (1-2 years): Prices likely remain stable or slightly increase, especially if new indications or formulations are introduced.
-
Mid-Term (3-5 years): Anticipate gradual price declines of 10-30% following biosimilar approval or patent expiration, aligned with market competitor activity.
-
Long-Term (5+ years): Market saturation with biosimilars or generics may reduce prices by 50% or more compared to initial launch prices, unless inflation or value-based pricing strategies are implemented.
Key Takeaways
-
Market size heavily depends on the therapeutic indication and patient population prevalence. A drug treating prevalent chronic conditions will dominate the market, exerting upward pricing influence.
-
Patent expirations and biosimilar entries are crucial inflection points influencing downward price pressures. Preparing for competitive shifts can inform strategic deployment and pricing.
-
Payer policies and reimbursement landscape significantly impact effective pricing and sales volume. Engagement with payers can optimize market access.
-
Global expansion potential may offer additional revenue streams, but currency, regulatory, and market variability introduce complexity.
-
Innovative pricing models, including value-based arrangements, can preserve margins amidst patent cliffs.
Frequently Asked Questions (FAQs)
1. How does patent expiration affect the price of NDC 46122-0740?
Patent expiration typically leads to increased competition from generic or biosimilar versions, resulting in significant price reductions—often 50% or more—due to market share redistribution and decreased brand dominance.
2. What role do biosimilars play in the pricing projections of this drug?
Biosimilar entry introduces competitive pressure, generally reducing prices by 15-30% initially, and potentially more as multiple biosimilars enter the market. This can accelerate the decline in brand-name drug prices.
3. Are international markets relevant for predicting the drug’s future pricing?
Yes. Regional pricing regulations, healthcare infrastructure, and market size impact global pricing trends. Many biotech drugs are priced differently in emerging markets, influencing overall revenue strategies.
4. How might evolving regulatory policies influence the drug’s market?
Regulatory decisions such as expanded indications, approval of new formulations, or changes in exclusivity rights impact market potential and, consequently, pricing strategies.
5. What impact do reimbursement policies have on the drug’s market value?
Reimbursement levels define the accessible price point for payers and patients. Favorable policies can sustain higher prices, while restrictive approaches can force price concessions and volume increases.
Conclusion
The market outlook for NDC 46122-0740 is characterized by stability in the short-term with downward price pressures emerging as patent protections expire and biosimilar competition intensifies. Strategic planning around regulatory developments, market expansion, and payer engagement is essential for optimizing revenue. Firms should monitor patent timelines, develop pipeline innovations, and adopt flexible pricing models to adapt to dynamic market conditions.
References
[1] Market trends in biosimilar competition and pricing projections based on FDA approvals and patent expirations (e.g., Center for Biosimilars, 2022).
More… ↓
